Shed­ding non-core units while load­ing up on cash, Mallinck­rodt bags $250M in CD­MO sale

6 years ago
Deals

A new play­er jumps in­to the heat­ed race for a sick­le cell cure, with help from Google's GV

6 years ago
R&D
Cell/Gene Tx

Alex Zha­voronkov fol­lows land­mark AI pa­per with $37M round for In­sil­i­co fea­tur­ing top-notch Chi­na VCs

6 years ago
Financing
AI

Fresh off the heels of mega fi­nanc­ing round, Ger­many's BioN­Tech makes $100M US IPO play

6 years ago
Financing

In­di­an man­u­fac­tur­ing play­er Ju­bi­lant poach­es top No­var­tis BD ex­ec to run their new biotech start­up in Yard­ley, PA

6 years ago
People
Pharma

No­var­tis makes new da­ta in­tegri­ty com­mit­ment

6 years ago
FDA+

Three biotechs hunt $336M-plus in a new round of IPOs — while Der­ma­vant pulls back

6 years ago
Financing

Neu­rotrope bat­tered in lat­est Alzheimer's flop; Platelet Bio­Gen­e­sis rais­es $26M-plus

6 years ago
News Briefing

CDER chief Janet Wood­cock has a mes­sage for phar­ma: 'It’s not work­ing, and it won’t work in the fu­ture'

6 years ago
People
Pharma

Aca­dia de­clares ear­ly win on Nu­plazid de­men­tia study, stun­ning an­a­lysts and send­ing shares soar­ing

6 years ago
R&D
Pharma

PhI­II lung can­cer da­ta sig­nal po­ten­tial ap­proval for As­traZeneca's Imfinzi

6 years ago
R&D

Tony Coles sets sail on new neu­ro pur­suit at Cerev­el, steer­ing Pfiz­er spin­out as CEO

6 years ago
People

Boehringer In­gel­heim's Ofev wins FDA ap­proval for use in scle­ro­der­ma pa­tients

6 years ago
Pharma
FDA+

Eli Lil­ly hus­tles up an im­pres­sive set of piv­otal da­ta for their $8B Loxo drug — as ri­val nips at their heels

6 years ago
R&D

Lon­don's 4BIO Cap­i­tal un­veils first close of $150M fund ded­i­cat­ed to ad­vanced ther­a­pies

6 years ago
Financing
Cell/Gene Tx

MIT’s star tech gu­ru Joi Ito re­signs biotech chair post in wake of Jef­frey Ep­stein scan­dal

6 years ago
People

A strong per­for­mance by AMG510 stokes fresh en­thu­si­asm on the fu­ture of Am­gen's land­mark KRAS G12C pro­gram — but ...

6 years ago
R&D

No­var­tis' late-stage block­buster push gets ma­jor boost with an­oth­er 'break­through' for MET ther­a­py

6 years ago
R&D

Psy­che­del­ic drug re­search breaks out of deep freeze as re­searchers head for the clin­ic with am­bi­tious tri­al plans

6 years ago
R&D

BioN­Tech part­ners with Bill and Melin­da Gates Foun­da­tion, scor­ing $55M eq­ui­ty in­vest­ment; BeiGene brush­es off short ...

6 years ago
News Briefing

Randy Schatz­man jumps to the helm of an­oth­er start-up; No­vo Nordisk vet lands top post at Macrophage Phar­ma

6 years ago
Peer Review

Stephen Hahn, 'clear fron­trun­ner' for FDA com­mish job, has met with Trump — re­ports

6 years ago
People
FDA+

Genen­tech reach­es set­tle­ment with Tai­wanese biotech ac­cused of steal­ing trade se­crets — but will keep su­ing ...

6 years ago
Pharma

Roche boosts can­cer ap­provals in Eu­rope, push­ing for a big­ger slice of the I/O pie

6 years ago
R&D
Pharma
First page Previous page 901902903904905906907 Next page Last page
A service from the Financial Times